Skip to main content
Psychopharmacology Bulletin › All Volumes & Issues › VOL 55 No. 3 › Incretin Mimetics (GLP-1...
GENERAL PSYCHIATRY

Incretin Mimetics (GLP-1 Agonists) as an Addition to the Psychopharmacology Armamentarium

Hend FM FR Alenezi, Ahmed Naguy
Psychopharmacology Bulletin 55(3) :26-30 , 2025/04/08

Abstract

The exploration of GLP-1 receptor agonists as pleiotropic agents in the treatment of neuropsychiatric disorders and substance use disorders is a rapidly evolving field. While early studies have shown promising results, much of the research is still nascent, and larger clinical trials are definitely needed to confirm the safety and efficacy of these agents on real grounds.

Keywords

addiction, alzheimer’s disease, anxiety, binge eating, GLP-1RAs, metabolic syndrome, mood

Access This Article

Choose an access option below to view the full article.

Subscriber Access

If you or your institution has a subscription, log in to access this article.

Log In
Not yet subscribed? View subscription options

Purchase Article

Buy single-article access with a one-time purchase.

$30.00
Add to Cart

How to Cite

Hend FM FR Alenezi, Ahmed Naguy. Incretin Mimetics (GLP-1 Agonists) as an Addition to the Psychopharmacology Armamentarium. Psychopharmacology Bulletin. 2025/04/08; 55(3):26-30.